The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Half Sinemet CR 25mg/100mg Prolonged-Release Tablets

Organon Pharma (Ireland) LimitedPA23198/004/006

Main Information

Trade NameHalf Sinemet CR 25mg/100mg Prolonged-Release Tablets
Active SubstancesLevodopa
Dosage FormProlonged-release tablet
Licence HolderOrganon Pharma (Ireland) Limited
Licence NumberPA23198/004/006

Group Information

ATC CodeN04BA Dopa and dopa derivatives
N04BA02 levodopa and decarboxylase inhibitor


License statusAuthorised
Licence Issued22/02/1993
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back